Femara (letrozole) or Arimidex (anastrozole) for breast cancer

More women will be taking Femara (letrozole) or Arimidex (anastrozole) for breast cancer.

Both are now approved for INITIAL therapy of metastatic breast cancer...as an alternative to tamoxifen.

Until now, tamoxifen was the gold standard for treating women with estrogen-receptor positive breast cancer. But Femara and Arimidex seem to work at least as well...if not better.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote